HKAM
GCVRZ

Horizon Kinetics Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Horizon Kinetics Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,940
Closed -$14K – 493
2019
Q4 		$14K Hold
15,940
– – ﹤0.01% 474
2019
Q3 		$9K Hold
15,940
– – ﹤0.01% 483
2019
Q2 		$8K Hold
15,940
– – ﹤0.01% 494
2019
Q1 		$7K Buy
+15,940
New +$7.44K ﹤0.01% 488

Horizon Kinetics Asset Management's GCVRZ Position: Q1 2020 in Review

Horizon Kinetics Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 15,940 shares — an estimated $14K sold.

Horizon Kinetics Asset Management first reported a position in GCVRZ in Q1 2019 and held it in 4 quarters. The position peaked at $14K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Horizon Kinetics Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Horizon Kinetics Asset Management sold 15,940 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $14K.
  • Horizon Kinetics Asset Management first reported a position in Sanofi Contingent Value Rights in Q1 2019 and held it in 4 quarters.
  • Horizon Kinetics Asset Management's Sanofi Contingent Value Rights position peaked at $14K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2020, filed 13 May 2020.